Delivery Order SPE2DB22D2006-SPE2DB25FW4GH
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,566.68 to AmerisourceBergen Drug Corp for Lupron Depot 45 mg 6-month kits, a specialty pharmaceutical product used in hormone therapy and cancer treatment. The contract was awarded on July 16, 2025, with an ultimate completion date of July 17, 2025, under firm fixed-price terms with no set-aside designation. Performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,331.98 to AmerisourceBergen Drug Corp for Lupron Depot 45 mg 6-month kits under a firm fixed price contract. The award was issued on July 24, 2025, with an ultimate completion date of July 25, 2025. This delivery order represents a non-set-aside award issued competitively to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company is headquartered. Lupron Depot is a hormone therapy...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $2,743.72 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Lupron Depot 45 mg six-month kits. The contract is a firm fixed-price delivery order with an ultimate completion date of August 26, 2025, and is not designated as a set-aside contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $2,675.01 firm-fixed-price delivery order is for the supply of Lupron Depot 45 mg 6-month kits. The contract has a performance period extending to June 2025 and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $2,743.72 to AmerisourceBergen Drug Corp for Lupron Depot 45 mg 6-month kits on August 13, 2025, with an ultimate completion date of August 14, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for Lupron Depot 45 mg 6-month kits, with a ceiling value of $1,371.86. This is a firm fixed-price delivery order with an ultimate completion date of August 21, 2025. The contract is not set-aside and was awarded competitively to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The place of performance is the...
- The Defense Logistics Agency awarded a delivery order valued at $17,759.51 to AmerisourceBergen Drug Corp for the supply of Lupron Depot 11.25 mg 3-month kits. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded with a completion date of September 9, 2025. The award was made to AmerisourceBergen's corporate office, with performance to be executed at the company's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 21, 2025, for the supply of Lupron Depot 45 mg 6-month kits with a ceiling value of $5,590.90. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's broader pharmaceutical supply agreement with DLA. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of April...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $20,048.58 to AmerisourceBergen Drug Corp for Lupron Depot 3.75 mg kits. This is a firm fixed-price, competitively awarded delivery order with an ultimate completion date of September 12, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026,...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Lupron Depot 45 mg 6-month kits, with a ceiling value of $2,057.79. This is a firm fixed-price, non-set-aside delivery order that will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 18, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW4GHDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lupron Depot 45 mg 6-month treatment kits valued at $8,003.70 under a firm fixed price contract with an ultimate completion date of September 19, 2025. This non-set-aside delivery order represents a pediatric or adult pharmaceutical procurement supporting military healthcare operations. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs across the Department of Defense and other federal agencies. This delivery order is executed under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp's federal contract portfolio demonstrates consistent capability in fulfilling competitive medical supply requirements for the Defense Logistics Agency and affiliated healthcare systems, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.0k | 9/18/25 |